• May 23, 2022
  • SK Capital

SK Capital Announces Richard Jackson as Managing Director

New York, May 23, 2022 – SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the specialty materials, specialty chemicals and pharmaceuticals sectors, today announced the hiring of Richard Jackson as Managing Director, Head of Capital Markets.  Mr. Jackson will be based in New York and brings three decades of investment banking and deal making experience across Europe and the US to SK Capital. In this newly established role, Mr. Jackson will lead the firm’s efforts in obtaining committed financing for new platform investments and be responsible for managing the capital structures of the existing portfolio companies as well as the refinancing of existing debt, IPO related activities and supporting the financing of portfolio company add-on acquisitions.

“We are pleased to welcome Richard to the SK Capital team. He brings the  experience, knowledge and track record  to successfully navigate the complexity in today’s Capital Markets, but more importantly we view him as an integral part of the firm’s growth,” said Jamshid Keynejad, Co-Founder of SK Capital.

Prior to joining SK Capital, Mr. Jackson was Managing Director and Head of Leveraged & Acquisition Finance for the Americas at HSBC Group, where he led a team of professionals focused on managing the origination and distribution of flow and acquisition debt financing, including Leveraged Loans and High Yield Fixed Income, across the full credit spectrum of HSBC’s client base. Mr. Jackson spent almost 30 years at HSBC in a career that encompassed senior roles across the firm’s Investment Banking business in London and New York.   

“I am excited about the opportunity to join the team at SK Capital. I have been fortunate to support the firm on a number of recent transactions within the current portfolio of companies and look forward to the new challenges and opportunities that lie ahead for me on the buy-side,” said Mr. Jackson.

About SK Capital

SK Capital is a private investment firm with a disciplined focus on the specialty materials, specialty chemicals, and pharmaceuticals sectors. The firm seeks to build strong and growing businesses that create substantial long-term economic value. SK Capital aims to utilize its industry, operating, and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth, and profitability, as well as lower operating risk. SK Capital’s portfolio of businesses generates revenues of approximately $15 billion annually, employs more than 20,000 people globally, and operates 191 plants in 32 countries. The firm currently has approximately $6.6 billion of assets under management. For more information, please visit www.skcapitalpartners.com.